Related Experiment Video
Updated: May 28, 2026

A Periprosthetic Joint Candida albicans Infection Model in Mouse
Published on: February 2, 2024
Microbiological Profile of Periprosthetic Infections Following Femoral Fracture: A Retrospective Analysis
Luca Bianco Prevot1, Edoardo Verme2, Livio Pietro Tronconi3,4
1Department of Biomedical Sciences and Public Health, University "Politecnica Delle Marche" of Ancona, 60124 Ancona, Italy.
Abstract:
Background: Implant-related infection following femoral fracture surgery is a severe complication in elderly patients and is associated with high morbidity and mortality. Most available evidence on periprosthetic joint infection (PJI) derives from elective arthroplasty populations, which differ substantially from patients undergoing surgery for femoral fractures. This study aimed to investigate the microbiological profile and clinical characteristics of implant-related infections after proximal femoral fracture surgery. Materials and Methods: A retrospective observational study was conducted on 20 patients aged ≥70 years who developed implant-related infection after surgical treatment of proximal femoral fractures between 2020 and 2025 at a referral trauma center. Surgical procedures included intramedullary nailing, hemiarthroplasty, and total hip arthroplasty. Only patients with Charlson Comorbidity Index ≥ 4 and infection occurring within one year of the index surgery were included. Clinical, surgical, microbiological, and antibiotic therapy data were retrospectively reviewed. Results: The cohort had a mean age of 82.4 years and a high comorbidity burden (mean Charlson index 4.8). The most frequently isolated pathogen was Staphylococcus aureus (25.9%), with 85% methicillin-resistant strains. Other pathogens included Enterococcus faecalis, Klebsiella pneumoniae, and Escherichia coli. Polymicrobial infections were observed in 25% of patients. One-year mortality was 25%. Conclusions: Implant-related infections after femoral fracture surgery represent a distinct clinical entity compared with elective PJI, characterized by frail patients and a higher prevalence of multidrug-resistant organisms. These findings highlight the need for tailored preventive and therapeutic strategies in this high-risk population.
Insights
Implant infections after femoral fractures in elderly patients are distinct from elective joint replacements, often involving multidrug-resistant bacteria and leading to high mortality. Tailored strategies are crucial for this frail population.
Area of Science:
- Orthopedic Surgery
- Infectious Diseases
- Geriatric Medicine
Background:
- Implant-related infections post-femoral fracture surgery pose significant risks in elderly patients.
- Existing data on periprosthetic joint infection (PJI) primarily from elective arthroplasty do not fully represent fracture populations.
- Understanding specific microbial profiles and clinical features is vital for this unique patient group.
Purpose of the Study:
- To investigate the microbiological landscape of implant-related infections following proximal femoral fracture surgery.
- To characterize the clinical presentation and outcomes of these infections in elderly patients.
Main Methods:
- Retrospective observational study of 20 patients (≥70 years) with implant-related infections after proximal femoral fracture surgery (2020-2025).
- Inclusion criteria: Charlson Comorbidity Index ≥ 4, infection within one year of surgery.
- Data reviewed: clinical, surgical, microbiological, and antibiotic therapy.
Main Results:
- The cohort (mean age 82.4 years) exhibited a high comorbidity burden (mean Charlson index 4.8).
- Staphylococcus aureus was the most common pathogen (25.9%), with 85% methicillin-resistant strains.
- Polymicrobial infections occurred in 25% of patients, and one-year mortality was 25%.
Conclusions:
- Implant-related infections post-femoral fracture surgery are a distinct entity from elective PJI.
- Frail elderly patients with these infections show a higher prevalence of multidrug-resistant organisms.
- Tailored preventive and therapeutic strategies are essential for this high-risk demographic.

